Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Nathanson

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1988
Stereospecificity of beta adrenergic antagonists: R-enantiomers show increased selectivity for beta-2 receptors in ciliary processJ A Nathanson
Current Eye Research|March 1, 1985
Biochemical and physiological effects of S-32-468, a beta-adrenoceptor antagonist with possible oculoselectivityJ A Nathanson
Life Sciences|May 26, 1980
Cerebral microvessels contain a beta 2-adrenergic receptorJ A Nathanson
British Journal of Pharmacology|May 1, 1981
Effects of a potent and specific beta 2-adrenoceptor antagonist on intraocular pressureJ A Nathanson
Science (New York, N.Y.)|May 25, 1979
Beta-adrenergic-sensitive adenylate cyclase in secretory cells of choroid plexusJ A Nathanson
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1992
Nitrovasodilators as a new class of ocular hypotensive agentsJ A Nathanson
British Journal of Pharmacology|November 1, 1984
ICI 118,551: an effective ocular hypotensive agent with selectivity for the ciliary process beta 2-adrenoceptor and with minimal cardiac side effectsJ A Nathanson
Investigative Ophthalmology & Visual Science|August 1, 1987
Atriopeptin-activated guanylate cyclase in the anterior segment. Identification, localization, and effects of atriopeptins on IOPJ A Nathanson
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1985
Differential inhibition of beta adrenergic receptors in human and rabbit ciliary process and heartJ A Nathanson
Science (New York, N.Y.)|January 5, 1979
Octopamine receptors, adenosine 3',5'-monophosphate, and neural control of firefly flashingJ A Nathanson
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1988
Stereospecificity of beta adrenergic antagonists: R-enantiomers show increased selectivity for beta-2 receptors in ciliary processJ A Nathanson
Current Eye Research|March 1, 1985
Biochemical and physiological effects of S-32-468, a beta-adrenoceptor antagonist with possible oculoselectivityJ A Nathanson
Life Sciences|May 26, 1980
Cerebral microvessels contain a beta 2-adrenergic receptorJ A Nathanson
British Journal of Pharmacology|May 1, 1981
Effects of a potent and specific beta 2-adrenoceptor antagonist on intraocular pressureJ A Nathanson
Science (New York, N.Y.)|May 25, 1979
Beta-adrenergic-sensitive adenylate cyclase in secretory cells of choroid plexusJ A Nathanson
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1992
Nitrovasodilators as a new class of ocular hypotensive agentsJ A Nathanson
British Journal of Pharmacology|November 1, 1984
ICI 118,551: an effective ocular hypotensive agent with selectivity for the ciliary process beta 2-adrenoceptor and with minimal cardiac side effectsJ A Nathanson
Investigative Ophthalmology & Visual Science|August 1, 1987
Atriopeptin-activated guanylate cyclase in the anterior segment. Identification, localization, and effects of atriopeptins on IOPJ A Nathanson
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1985
Differential inhibition of beta adrenergic receptors in human and rabbit ciliary process and heartJ A Nathanson
Science (New York, N.Y.)|January 5, 1979
Octopamine receptors, adenosine 3',5'-monophosphate, and neural control of firefly flashingJ A Nathanson
Pageof 7